AGIC Capital Completes Growth Equity Investment into AP Technologies

AGIC Capital (“AGIC”), a growth-oriented European-Asian private equity firm with $2.2 billion of assets under management has completed the investment of an undisclosed amount into AP Technologies (“AP Tech”), an emerging medical device contract manufacturer focusing on highly-engineered solutions for critical healthcare applications using the latest extrusion and catheter assembly processes.

Founded in 2013, AP Technologies is a premier medical tubing and catheter contract manufacturer specializing in the design, development, and production of complex medical extrusions and interventional catheters. The company serves a number of blue-chip customers in the area of diagnostics, interventional cardiology, neurology and diabetic care and is poised to benefit from the structural growth in diagnostic & therapeutic solutions in these industries in Asia and globally.

The investment into AP Tech marks AGIC’s first transaction in Asia with its Fund II and marks another milestone in its continued development and expansion of geographic focus along the Europe-Asia axis.

Charles Tang, CEO and Co-Founder of AP Tech, commented: “We are thrilled to be partnering with AGIC as a leading life science investor to further grow our core business in medical tubing and catheter manufacturing. Their support will allow us to make key investments in enhancing our technological capabilities, while helping us to accelerate our global development strategy. We look forward to the next steps of a successful journey with the AGIC team.

Ken He, Director at AGIC, said, “We are very impressed with AP’s strong technical capabilities, focus on product quality, and proven track record in working with world-class customers and fulfilling their unique demands, which is reflected in the company’s impressive growth over the years. We look forward to contributing our capital and life science expertise to AP’s growth and expansion.”


Newsletter Updates

Enter your email address below and subscribe to our newsletter